Dual Antiplatelet Therapy or Dual Pathway Inhibition

Thrombosis and Haemostasis 2023 Editors' Choice Papers

“…Such bleeding risk is increased further among East Asians. 23,24 To address these issues, the systematic review and meta-analysis from Gorog et al 25 compared DAPT between East Asians and Western patients and highlighted that de-escalating DAPT in East Asians indeed reduced bleeding without sacrificing the anti-ischemic effect following acute coronary syndrome. The SWAP-AC Study 26 in turn offered significant evidence favoring the transition from DAPT to dual pathway inhibition in patients with coronary artery disease.…”